BIOXCEL THERAPEUTICS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

BTAIQ

organization

SIC: 2834Active: 2022–2025

Also known as: BioXcel Therapeutics, Inc.

SEC Insider

$161.9M

596 transactions

Summary

BIOXCEL THERAPEUTICS, INC. (BTAIQ) is an organization. Their largest government contract source is Department of Veterans Affairs at $0. Political activity spans from 2022 to 2025.

Contracts by Agency

1 agencies

#	Agency	Total Awarded	Awards
1	Department of Veterans Affairs	$0	2

Individual Awards

2 awards (top by amount)

Date	Agency	Description	Amount	NAICS
2023-02-10	Department of Veterans Affairs	INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS	$0	PHARMACEUTICAL PREPARATION MANUFACTURING
2025-12-10	Department of Veterans Affairs	2026 PUBLIC LAW PRICING UPDATE	$0	PHARMACEUTICAL PREPARATION MANUFACTURING

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

BIOXCEL THERAPEUTICS, INC. — Contributions, Lobbying & Contracts | Poliscope